Thomas Horn is a professional with extensive experience in the biotechnology and pharmaceutical fields. Currently serving in External Innovation at Biogen since October 2025, Thomas has held various leadership roles such as Investment Diligence & Operations Lead at Curie.Bio and Director of Search and Evaluation at Day One Biopharmaceuticals. Previous positions include Senior Research Scientist I at Gilead Sciences and Senior Scientist at Agenus, focusing on T-Cell Biology. Thomas also contributed to postdoctoral research at Novartis and the DKFZ German Cancer Research Center, specializing in drug combination identification and genetic interaction mapping. Academic credentials include a PhD in Natural Sciences and an MBA from Gies College of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices